What is the incidence and treatment of uterine prolapse in pigs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Uterine Prolapse in Pigs: Incidence and Management

Incidence

The annualized incidence rate of uterine prolapse in sows is approximately 3.8 cases per 1000 sow-years, with nearly 1% (0.8%) of sows removed from production due to prolapses. 1

  • The majority of prolapse cases (60.9%) occur during the first 0-4 weeks after farrowing 1
  • Peak incidence occurs at 16 weeks after service, with rates 30.6 times higher than during the first 14 weeks 1
  • Vaginal prolapse specifically accounts for 6.3% of dystocia cases in swine, while vesical flexion (bladder displacement) represents 3.1% 2

Risk Factors

Parity 3 or higher sows face 1.5-1.8 times higher prolapse risk compared to first-parity animals. 1

Key risk factors include:

  • Parity: Sows in parity 3+ have significantly elevated risk, with 50% of vesical flexions and 78.8% of vaginal prolapses occurring around the third parturition 1, 2
  • Re-service: 1.3 times higher incidence in re-serviced sows 1
  • Season: Summer, autumn, and winter services carry 1.3-1.5 times higher risk than spring 1
  • Gestational length: Shorter gestation (≤113 days) increases risk 1.3-1.5 times 1
  • Litter characteristics: Fewer total piglets born (≤11) and two or more stillborn piglets each increase risk by 1.2-1.4 times 1

Clinical Presentation

Most prolapses (81.2% of vesical flexions and 72.7% of vaginal prolapses) are not presented until tissue displacement becomes stationary. 2

  • Rectal tissue displacement accompanies 31.2% of vesical flexions and 21.2% of vaginal prolapses 2
  • Differentiation between vesical flexion and vaginal prolapse requires catheterization of the bladder, performed in 56.2% of cases for both diagnostic and therapeutic purposes 2

Treatment Approach

Manual reduction followed by retention sutures represents the primary treatment strategy, with catheterization maintained for an average of 6 days (maximum 19 days) in vesical flexion cases. 2

Immediate Management:

  • Manual replacement of prolapsed tissue 3
  • Bladder catheterization using Foley catheter for vesical flexion cases 2
  • Vaginal retention sutures (Bühner technique) applied in 60.6% of vaginal prolapse cases after reduction 2

Prevention Strategies:

  • Enhanced monitoring of high-risk sows (parity 3+, re-serviced, summer/autumn/winter services) 1
  • Early detection during the critical 16-week post-service period and first 4 weeks postpartum 1
  • Attention to sows with shorter gestational lengths and higher stillborn rates 1

Common Pitfalls

Delayed presentation is the most significant management challenge, with most cases not receiving veterinary attention until tissue displacement becomes fixed. 2

  • Failure to differentiate vesical flexion from vaginal prolapse without proper catheterization leads to inappropriate treatment 2
  • Inadequate retention suture placement or premature catheter removal increases relapse risk 2
  • Missing the critical monitoring window at 16 weeks post-service when incidence peaks dramatically 1

References

Research

Management of uterine and vaginal prolapse in the bovine.

The Veterinary clinics of North America. Food animal practice, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.